SyneuRx International Corp.

PANTALANDIR

acids for pharmaceutical purposes; antibiotics; viral antibiotics; cachets for pharmaceutical purposes; cachou for pharmaceutical purposes; candy, medicated; candy for medical purposes; capsules for medicines; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; drugs for medical purposes; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions; medicines for human purposes; medicines for veterinary purposes; preparations of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for therapeutic or medical purposes; nutritional supplements; ointments for pharmaceutical purposes; pastilles for pharmaceutical purposes; lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes; pharmaceutical preparations; pharmaceuticals; poultices; pre-filled syringes for medical purposes; salts for medical purposes; sedatives; tranquillizers; suppositories; syrups for pharmaceutical purposes; tonics; inhalation; drugs for pulmonary administration;

SRX

The mark consists of the stylized letters SRX in white on a blue grey oval background that fades from darker to lighter from the top to the bottom.;Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes;The color(s) blue grey and white is/are claimed as a feature of the mark.;Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services;